AKT1 and breast carcinoma: Endocrine-resistant breast cancer cells promote COX-2 expression in TAMs via the JNK/c-Myc/arginase-1 pathway and further promote endocrine resistance in breast cancer cells by activating the PI3K/Akt/mTOR pathway, forming a positive feedback loop between TAMs and breast cancer cells [150].